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Abstract
Acetylcholine (ACh) contributes to learning processes by modulating cortical plasticity in terms of intensity of neuronal
activity and selectivity properties of cortical neurons. However, it is not known if ACh induces long term effects within the
primary visual cortex (V1) that could sustain visual learning mechanisms. In the present study we analyzed visual evoked
potentials (VEPs) in V1 of rats during a 4–8 h period after coupling visual stimulation to an intracortical injection of ACh
analog carbachol or stimulation of basal forebrain. To clarify the action of ACh on VEP activity in V1, we individually pre-
injected muscarinic (scopolamine), nicotinic (mecamylamine), a7 (methyllycaconitine), and NMDA (CPP) receptor
antagonists before carbachol infusion. Stimulation of the cholinergic system paired with visual stimulation significantly
increased VEP amplitude (56%) during a 6 h period. Pre-treatment with scopolamine, mecamylamine and CPP completely
abolished this long-term enhancement, while a7 inhibition induced an instant increase of VEP amplitude. This suggests a
role of ACh in facilitating visual stimuli responsiveness through mechanisms comparable to LTP which involve nicotinic and
muscarinic receptors with an interaction of NMDA transmission in the visual cortex.
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Introduction
Modulation of visual responses in the primary visual area (V1)
by acetylcholine (ACh) contributes to visual attention [1] and
learning [2]. In V1, ACh augments cortical plasticity in terms of
intensity of neuronal activity [2,3,4,5,6,7,8], preferred responses of
visual neurons [6,9], receptive field properties [6,10] and
performance in visual learning in the visual water maze [2].
Neuronal effects of ACh vary from activation to inhibition [6,11]
depending on the type of muscarinic or nicotinic cholinergic
receptors (mAChR and nAChR) activated and location. Overall,
the majority of anatomical and physiological data in V1 to date
suggests that ACh primarily enhances thalamocortical inputs
through the a4b2 nAChR located on the thalamocortical fibres
and M1 mAChRs on glutamatergic cells of layer IV [6,7,12].
Alternatively, ACh has been shown to decrease the strength of
corticocortical input through M2 and M4 mAChRs located on
corticocortical fibres [7,13]. ACh interaction with GABAergic
interneurons through a7 nAChRs [14,15] also contributes to the
modulation of sensory responses. The rapid desensitization and
high calcium permeability properties of a7 nAChRs could also
play a key role in cortical synaptic plasticity, although this action
has not been investigated in V1 [16,17].
Long-term modification of cortical responsiveness such as long-
term potentiation (LTP) or depression (LTD) has been proposed as
a necessary correlate of learning. The cholinergic system has been
shown to enhance long-term activation in certain cortical areas
[8,10]. Repetitive pairing of cholinergic and auditory stimulation
over a period of two weeks results in long-term cortical map
reorganization [18]. Furthermore, pairing cholinergic activation
with somatosensory stimulation [19] induces a long-term ($1h )
increase of cortical electrophysiological responses. The involve-
ment of ACh in pure LTP or LTD mechanisms, which involves
NMDA receptors (NMDAR), has also been demonstrated in the
hippocampus and cortex, including V1. Electrophysiologically
induced LTP [20,21] or LTD [22,23] in V1 or V1 slices [4] is
dependent on a cholinergic component. Moreover, LTP and LTD
are diminished in V1 of M2/M4 and M1/M3 double knock out
mice, respectively [24]. This further indicates a role for ACh in
cortical synaptic plasticity through an integrated action of different
mAChR subtypes.
These data suggest that ACh may contribute to cortical LTP in
V1, similar to other cortical areas [18,19]. The present study was
designed to test the hypothesis that pairing of external stimuli with
cholinergic activation induces a long-term enhancement of
integrated cortical responsiveness in V1. For this purpose, visual
evoked field potentials (VEP) were measured over the course of 4–
8 h in V1 after a transient pairing of patterned visual stimulation
with local administration of the ACh analog carbachol (CCh) or
electrical stimulation of the cholinergic projections to V1. In an
attempt to clarify the underlying mechanisms and a possible link
with classical LTP mechanisms, the involvement of mAChRs,
nAChRs or NMDARs in these responses were tested using
scopolamine (a non-selective mAChR antagonist), mecamylamine
(non-selective nicotinic receptors antagonist), or -3-(2-carboxypi-
perazin-4-yl)-propyl-L-phosphonic acid (CPP, NMDAR antago-
nist). Moreover, the specific role of a7R was tested using
methyllycaconitine (MLA, a a7 nAChR selective antagonist) to
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5995evaluate the influence of this receptor which has recently been
recognized for its involvement in cortical plasticity [14,17].
Materials and Methods
Animal preparation
Adult Long-Evans rats (n=60, 250–300 g) were obtained from
Charles River Canada (St-Constant, Quebec, Canada) and
maintained in a 12 h light/dark cycle with free access of food
during both the pre- and post-implantation period. Two sets of
experiments were performed to evaluate the long-term effects of
cholinergic activation paired with visual stimulation on VEPs, i.e.
the effects sustained more than 1 h following transient cholinergic
stimulation. First, CCh intracortical (i.c.) injections (n=10) were
compared to vehicle injections (n=11) in order to establish the
effects of cholinergic activation on VEPs in V1. To verify the
extent of the long-term effects of CCh, 3 animals were tested for an
8 h period. To verify that CCh intracortical infusion mimicked the
activation of cholinergic basalo-cortical projections, an electrical
stimulation [25] of the V1 projecting cholinergic neurons from the
horizontal limb of the diagonal band of Broca (HDB) was
performed on another set of animals (n=4). Second, CCh was
used to elucidate the receptors involved in this process. For this
purpose 5 different groups in which the following antagonists were
injected 1 h prior to CCh were examined: scopolamine
(Sco+CCh, n=4), mecamylamine (Mec+CCh, n=5), MLA+CCh
(n=6), CPP+CCh (n=6) and the control group, aCSF+CCh
(n=8). Complementary experiments to better evaluate the
involvement of muscarinic receptors included a group of
scopolamine i.p. injection 30 min before CCh (Sco i.p.+CCh,
n=5) or simultaneously with CCh (CCh+Sco i.p., n=2, control
group). The antagonistic effect of scopolamine occurs 30 min after
it is injected i.p. and persists for around 120 min [26]. These two
groups corresponded to inhibition of brain mAChR at the time of
or just following CCh injection, respectively. Guidelines set out by
the Canadian Council for the Protection of Animals were followed
for all procedures and approved by the local Animal Care
Committee, ‘‘Comite ´d eD e ´ontologie de l’Expe ´rimentation sur les
Animaux’’ at the University of Montreal.
Surgery
Animals were anaesthetized with isoflurane (induction 5%,
maintain 1.5%) and placed in a stereotaxic apparatus. Throughout
the experiment, the rectal temperature was maintained at 37uC
using a thermostatically controlled heating pad (FHC, Bowdoin-
ham, ME, USA). A dental drill was used to make a hole (3.0 mm
diameter) in the skull above the left visual cortex. A tungsten
electrode (conductance ,0.8 MV; FHC, Bowdoinham, ME) along
with an electrode guide (polyurethane tubing) was then inserted in
V1 (mm from Bregma: AP27.5, ML+4.0, DV20.5 from dura
mater surface) and tested for VEP response. The electrode was
removed but the electrode guide was left in place at the surface of
the skull. A push-pull cannula guide (Plastics1, Roanoke, VA) was
placed adjacent to the electrode tip (mm from Bregma: AP27.5,
ML+3.6, DV20.7 mm, 30u angle from verticality) (Fig. 1). The
stimulating tungsten electrode, denuded at each tip, was implanted
Figure 1. Design of the experiment. (A) Schematic diagram illustrating the chronic implantation of the recoding electrode in V1 and the push-
pull cannula guide as well as the lateral stimulation of the retina with a horizontal grating displayed on a computer screen. The push-pull cannula
guide and the recording electrode guide were implanted in visual cortex 2 days before VEP recording. (B) Visual stimulation. Rats were stimulated by
displaying trains of sinusoidal horizontal grating (100 ms, 0.033 Hz, contrast 100%) for 8 cycles. Each cycle consisted of 10 min visual stimulation
every 30 min. The VEP was obtained by averaging the 20 single electrophysiological signals evoked by the 20 presentations of the grating during the
stimulation period. (C) Histology of the injection and recording sites. Schematic coronal section at the site of recording and cresyl violet-stained
coronal section showing electrolytic lesion indicating position of electrode tip (arrow) and location of the infusion cannula (arrow head). Electrode
and cannula tips are adjacent.
doi:10.1371/journal.pone.0005995.g001
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Bregma: AP20.3, L+2.0, DV29.0). Two nylon screws (Small
parts, Miami Lakes, FL, USA) were screwed into the skull, then
the guides and the HDB implanted electrode were secured with
dental cement. After suturing the incised skin, local anaesthesia
(xylocaine 2%, Astra Zeneca, Mississauga, Canada) was topically
administered to the wound and animals were returned to their
cages.
Drug infusion
All drugs were obtained from Sigma Chemical Co and dissolved
in a freshly made artificial cerebrospinal fluid (aCSF: NaCl, 1.0 M;
NaHCO3, 0.5 M; KCl, 1.47 M; MgSO4, 1.25 M; KH2PO4,
0.25 M; C6H12O6, 0.01 M; CaCl2, 1.73 M pH 7.4). Drugs (CCh,
5 mM; scopolamine, 3 mM; mecamylamine, 10 mM; CPP, 20 mM;
MLA, 50 nM) or vehicle (aCSF) were injected once intracortically
(i.c., 1 ml/min, 10 min, simultaneously to one session of VEP
recording) using an injection pump (Harvard Apparatus, Hollis-
ton, MA, USA). The push-pull cannula allowed for excess fluids at
the injection site to be discarded and limited the accumulation of
the drug within the cortex. Intraperitoneal injection of scopol-
amine (i.p., 10 mg/kg) simultaneously or 30 min prior CCh
injection was also performed to compare i.p and i.c. injection
regimens and match previous experiments [21,27].
HDB electrical stimulation
Electrical stimulation was performed over 10 min period using
pulses (100 Hz, 0.5 ms, 50 mA, 1 sec on/1 sec off) generated
(Pulsemaster A300, WPI, Sarasota, FL) and delivered through an
isolation unit (WPI 365, WPI, Sarasota, FL) [25].
Visual stimulation paradigm
VEPs were elicited by a patterned visual stimulation provided by
trains of sinusoidal gratings displayed on a computer screen in the
dark. The computer monitor (30625 cm, Titanium; luminance
21 cd/m
2; Apple Computer Inc., Cupertino, CA, USA) was placed
parallel to the midline of the rat at a distance of 30 cm [28,29].
Trains (100 ms on/30 sec off, 10 min) of horizontal sinusoidal
grating (contrast 100%, 0.12 cycle/deg) were produced by Vpixx
software (v 8.5; Sentinel Medical Research Corp., Quebec,
Canada). Selected orientation and spatial frequency of the grating
were based on previous studies [27,28,29]. Between each grating
and during the rest period, the computer screen displayed a neutral
grey stimulus with the same mean luminance as the gratings.
Visual evoked potentials recording procedure
Two days after implantation, rats were placed in the stereotaxic
frame under anaesthesia (isoflurane, 1.5%) for VEP recording.
The polyurethane tubing (electrode guide) was removed, leaving a
hole through the dental cement over V1 through which the
electrode was inserted. The electrode was placed 0.5 mm below
the dura mater. The penetration of the electrode through the dura
mater was identified by the 50% reduction of the mean amplitude
of the noise signal without visual stimulation monitored by the
audio monitor (AM10, Grass Technologies, Astro-Med, West
Warwick, RI, USA) and data acquisition program. The cannula
was also inserted within the cortex through the implanted guide.
VEPs were calculated by averaging 20 electrical responses of
extracellular field potentials over the 10 min stimulation period
(trains of 100 msec visual stimuli, 0.03 Hz, Fig. 1). Evoked
responses were amplified (50006) and filtered at 3 Hz,1 kHz
(Grass Inc, West Warwick, RI, USA) and collected with the data
acquisition system MP100 and Acknowledge software (v 3.8;
Biopac system Inc, Goleta, CA, USA). The amplitude (difference
between negative peak and positive peak) and latency (time spent
between the artefact of stimulation and the first negative peak) of
the VEPs were calculated using this software.
Repetitions of VEP recording were performed every 30 minutes
during a 4 h period (Fig. 1). To verify the extent of the long-term
effects of CCh, 3 additional animals were tested for an additional
4 h period with the same frequency of VEP recording (sixteen
repetitions of VEP recording per animal). Sequence of drug
injections were as follows: 1) two baseline VEPs were obtained; 2)
then antagonists were injected during the next VEP recording
session; 3) then one further VEP was recorded to verify that
antagonists or vehicle had no effect by themselves on VEP
amplitude; 4) then CCh was injected during the next VEP
recording and VEP were recorded for 4 additional periods.
Histology
At the end of the experiment, an electrolytic lesion was
performed to verify the recording site. The animal was then
sacrificed by the administration of pentobarbital (30 mg/kg i.p.),
the brain was removed, frozen at 250uC in isopentane, and
sectioned at 20 mm through the visual cortex using a cryostat
(Microm, ESBE, Markham, ON). The sections were then stained
with cresyl violet and electrode placement verified.
Statistical analysis
All quantitative data and the significance of difference in the
amplitude of the VEPs between each group and each time point
weretested by a mixed model ANOVA with a repeatedfactor(time)
and a non-repeated factor (group). The mixed model ANOVA was
used for the 2 sets of experiments, i.e. 4 groups (control, CCh, HDB
stimulation, Sco(i.p.)+CCh), or 5 groups (Mec+CCh, MLA+CCh,
CPP+CCh, Sco+CCh and aCSF+CCh). In case of a significant
(p,0.05) interaction between these factors, a one-way ANOVA
followed by the post-hoc LSD test was performed for each time
point in order to evaluate drug effects. The same analytical method
was applied for the latency. All statistical analyses were carried out
with SPSS 16.0 for Windows XP (SPSS Inc., Chicago, IL, USA)
with a significance level of p,0.05.
Results
Cholinergic stimulation induces a long-term increase of
VEP amplitude
In our experimental conditions, the VEP was recorded as a
wave composed of a negative peak followed by a positive deviation
(Fig. 2) corresponding to electrophysiological signals recorded in
cortical layer IV [19]. Mean amplitude difference between
negative and positive peaks of the baseline VEP recorded was
0.96560.08 mV. The amplitude (F(7,70)=1.915, p=0.080) and
the latency (F(7,70)=1.275, p=0.113) of the VEP in the control
animals did not change during the extent of the recording session
(eight stimulations, 4 h, Fig. 2 and Table 1).
The mixed model ANOVA revealed a significant interaction of
time and group in the amplitude (F(21,182)=10.505, p,0.001)
between the control group and CCh injected, scopolamine
injected (i.p.) and HDB stimulated group. One-way ANOVA at
each time point revealed that a single injection of the cholinergic
agent CCh paired with visual stimulation after stabilisation of the
VEP (at t=60 min), induced an increase (range 27–56%) in VEP
amplitude that lasted for the whole period of stimulation (4 h)
(LSD test, p,0.0001 compared to sham animals, Fig. 2). In the
animals tested for a longer period of time (8 h), the enhanced
effects were sustained for 6 h after which (remaining 2 h) there was
Cholinergic Enhancement of VEP
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injection or electrical stimulation paired with visual stimuli. (A) Representative wave of the VEP recorded before (grey line) and after (black line) CCh
injection or HDB stimulation. The recorded wave was composed of a negative peak followed by a positive deviation representative of layer 4 field
potentials trace. (B) Long-term effect on VEP amplitude of CCh infused in V1 (open square) or of HDB stimulation (triangle). After 2 periods of baseline
recording (0 and 30 min), application of CCh or HDB stimulation (indicated by arrow) produces an increase of VEP amplitude observed for several
hours after CCh infusion or HDB stimulation. Error bars indicate the SD values.
doi:10.1371/journal.pone.0005995.g002
Table 1. Amplitude of VEP normalized after CCh injection or HDB stimulation and drug treatment.
Amplitude (%) 0 min 30 min 60 min 90 min 120 min 150 min 180 min 210 min
Cholinergic enhancement
Control 100 99611 86619 91617 83629 84615 94612 92611
Carbachol (CCh) 100 101611 127639* 151641* 142632* 144612* 156621* 149616*
HDB stimulation 100 95604 154603* 144603* 140621* 159602* 126619* 147622*
Sco (i.p.)+CCh 100 90614 54602* 89614 78615 86619 95618 114608
CCh+Sco (i.p.) 100 95608 130645* 182640* 165617* 148624* 162604* 153625*
Pharmacological treatment
aCSF+CCh 100 95615 105613 92612 115618 122614 130618 112613
Sco (i.c.)+CCh 100 78626 108634 93624 64605# 72616# 84629# 85622#
Mec+CCh 100 99610 115610 101610 77621# 97608# 90609# 91611#
MLA+CCh 100 102606 94607 83615 152629# 100622# 86606# 131608#
CPP+CCh 100 106622 91608 111616 88614# 108618 100612# 81615#
Values are expressed in mean6SD. For the first set of experiment (cholinergic enhancement) CCh infusion and HDB stimulation were administrated at t=60 min. For
pharmacological treatment, antagonists were injected at t=60 min followed by CCh at t=120 min.
*p,0.05, compared to control, ANOVA and LSD post-hoc.
#p,0.05, compared to aCSF+CCh, ANOVA and LSD post-hoc.
doi:10.1371/journal.pone.0005995.t001
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anaesthesia. The electrical stimulation of HDB paired with visual
stimulation induced a long-term amplitude elevation of VEP
(Fig. 2; Table 1), which was maintained during the whole period of
time and was as great as CCh induced VEPs (compared to control
group, p,0.001). There was no difference between the amplitude
of VEPs induced by the CCh as compared to stimulation of HDB.
Latency of VEP across the groups did not differ (Table 2, mixed
model ANOVA, F(21,182)=1.429, p=0.143).
Effects of muscarinic, nicotinic and NMDA receptor
inhibition on the amplitude enhancement of the VEPs
The injection of inhibitors before the induction of CCh
enhancement effect showed a significant interaction in amplitude
between time and injected drugs (F(28,168)=7.979, p,0.001) but not
in the latency (F(28,168)=1.105, p=0.338). The amplitude of the
basal VEPs (before infusion of CCh) was not affected by muscarinic
(one-way ANOVA, p=0.726), nicotinic (p=0.236) and NMDA
receptor inhibition (p=0.115) during this administration nor 30
minutes after compared to the aCSF injected group. This suggests
that none of the drugs injected contributed significantly to the
baseline electrophysiological response to visual stimulation before
CCh injection. Scopolamine (p,0.001), mecamylamine (p=0.024)
and CPP (p=0.046) pre-treatment prevented the CCh-induced
long-term enhancement of the amplitude of the VEPs (Fig. 3,
Table 1). MLA showed fluctuating results (compared to the aCSF
group values), that is, an increased VEP amplitude during CCh
infusion (p=0.003) and 2 h after CCh infusion (p=0.02), but a
decreased amplitude in between these two time points. The latency
was unchanged for each group (Table 2, p=0.086). VEP amplitude
was however reduced (up to 32% decrease compared to control) at
t=120 min when CCh was infused in the scopolamine group
(p=0.028 i.c. and p=0.048 i.p). Moreover, there was no effect of
scopolamine (i.p.) when it was injected simultaneously with CCh
(Table 1), suggesting that mAChRs do not contribute directly to the
enhanced VEPs of CCh.
Discussion
The principal objective of this study was to pharmacologically
analyze the long-term effect of transient pairing of visual stimulation
with cholinergic activation on cortical neuronal functioning. This
was achieved by measuring changes in evoked potentials in V1 as a
functionoftime.Theresultsshowedalong-termenhancementinthe
amplitude of the VEPs for at least 6 h when the cholinergic system
was stimulated either from the cortex or the basal forebrain. This
effect was mediated by different types of receptors, i.e. mAChRs and
nAChRs as well as NMDARs but not a7 nAChRs. It is concluded
that cholinergic agents induced LTP-like events in the cortex by
triggering intracellular NMDAR pathways in glutamatergic cells.
We discuss below the role of the cholinergic system in modulating
cortical response to visual stimulation, its possible intracellular
pathways and its relation to attention and learning processes.
Acetylcholine modulates cortical responses in adult
visual cortex
The results presented here demonstrate that a single synchroni-
zation between visual stimulation and cholinergic activation by CCh
or electrical stimulation of the HDB was sufficient to induce a
persistent increase of VEP amplitude lasting forseveral hours.Similar
results were obtained by combining CCh injection and direct dorsal
lateral geniculate nucleus tetanic stimulation in an LTP paradigm
[21], and electrical basal forebrain stimulation combined with tactile
stimulation [19,30,31]. As well, these results corroborate data
obtained in cats, showing a long lasting response synchronization
[8] or receptive field plasticity [10] of cortical visual cells after co-
application of cholinergic agonists and light stimuli. These results
confirm in vivo that long-term effects of visual stimulation are
dependent on cholinergic activation. Interestingly, there was no
spontaneous enhancement of VEPs amplitude in control conditions.
This suggests that the low frequency visual stimulation in our
experimental conditions did not increase ACh extracellular levels
enough for inducing long-term effects in the control conditions. In
agreement with this, it has been shown that visual stimulation with
low frequency (0.067 Hz) checkerboards does not induce cortical
long-term changes [32]. High frequency (9 Hz) stimulation does
induce long-term changes in an effect termed sensory LTP [32],
suggesting different neurobiological mechanisms involved in high and
low frequency sensory stimulation.
Involvement of NMDA receptors
The cessation of CCh-induced long-term enhancement of
cortical response to visual stimulation during NMDAR inhibition
Table 2. Latency of VEP after CCh injection or HDB stimulation and drug treatment.
Latency (ms) 0 min 30 min 60 min 90 min 120 min 150 min 180 min 210 min
Cholinergic enhancement
Control 36633 5 633 7 633 5 643 5 623 3 643 4 633 5 64
Carbachol (CCh) 37633 7 623 6 643 4 632 9 632 6 653 1 633 1 63
HDB stimulation 35643 2 623 3 633 3 633 5 633 3 643 6 613 5 63
Sco (i.p.)+CCh 37614 1 614 0 624 0 623 5 643 8 633 9 653 7 62
CCh+Sco (i.p.) 38613 8 633 5 613 3 613 3 613 5 653 3 633 6 61
Pharmacological treatment
aCSF+CCh 38623 7 643 5 643 3 633 6 633 2 633 2 633 5 62
Sco(i.c.)+CCh 38653 7 624 1 613 9 634 3 654 0 664 4 653 9 66
Mec+CCh 39613 8 633 8 623 7 664 6 634 5 643 0 643 8 64
MLA+CCh 40624 1 643 9 623 7 643 6 643 7 633 9 633 7 62
CPP+CCh 39633 6 643 6 623 4 633 8 623 8 653 1 643 0 66
Values are expressed in mean6SD of ms after the stimulation artefact. There was no effect of the treatment on latency.
doi:10.1371/journal.pone.0005995.t002
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stimulation and NMDAR transmission [33,34,35]. The long-term
enhancement of VEP reported here is similar to LTP mechanisms
whereby synaptic strength is increased by the opening of NMDAR
which launches a Ca
2+ influx followed by an upregulation of
glutamatergic receptors [36]. LTP occurrence is accompanied by
an amplification of VEP [20], suggesting that the changes seen in
the present study could reflect LTP.
The involvement of NMDAR is implicated in plasticity in the
juvenile and adult visual cortex [37,38] suggesting that NMDAR is
a key factor in the plasticity induced by thalamocortical inputs.
Although the occurrence of LTP peaks during the development
period and drastically drops in the adult cortex, our results
indicates that LTP-like mechanisms could participate in cortical
plasticity in adult rats similar to what is reported in cat [39] and
mouse [37]. Our results further implicate that these mechanisms
are dependent on cholinergic mechanisms.
Involvement of muscarinic receptors
GiventhatmAChRsarewidelyexpressedinthevisualcortex-the
predominant postsynaptic mAChR being M1 subtype and the
presynapticmAChR beingM2[40]- and thatM1andM3receptors
are involved in hippocampal LTP [41], it was expected that
inhibition of these receptors would abolish long-term enhancement
of VEP. The present results of scopolamine administration verified
this hypothesis since no long-term changes in VEP amplitude were
seen after scopolamine infusion prior to CCh. This effect was robust
and stable. Interestingly, i.p. infusion of scopolamine prior to CCh
led to the same results as cortical infusion confirming that
scopolamine i.p. could act at a local cortical target [21,27,42].
However, three findings suggest that mAChRs are involved in the
induction of pathways generating long-term enhancement of
electrophysiological responses, acting as a trigger mechanism rather
than directly enhancing the ongoing neuronal excitability. First, the
VEP amplitude was significantly decreased compared to baseline at
the time of CCh infusion under scopolamine conditions which
suggests that CCh may have a depressing effect during mAChRs
antagonism. This effect might be mediated by nAChRs [16,43],
which could inhibit glutamatergic neurons through 1) activation of
a4b2o ra7 nAChRs located on GABAergic neurons [14] or 2)
disinhibition of inhibitory interneurons by blocking of M2 mAChR
expressed by the GABAergic interneurons [44,45]. Second, when
mAChRs were fully inhibited secondary to CCh action (simulta-
neous scopolamine i.p. injection and CCh i.c. injection group, see
methods), the enhanced long-term effects of CCh were not affected.
This result suggests that mAChR activation is required for priming
long-term enhancement of VEP but not directly for enhancing
neuronal activity that contributes to the increase in amplitude of
subsequent VEPs. This result contrasts with a recent study showing
impairment of auditory memory when scopolamine was adminis-
tered immediately after the cholinergic-paired training of the animal
[42]. However, the electrical cortical responses were not recorded in
Figure 3. VEP amplitude changes after pharmacological infusion of drugs in V1. Effects of scopolamine (B, Sco+CCh), CPP (C, CPP+CCh),
mecamylamine (D, Mec+CCh) or MLA (E, MLA+CCh) infusion prior to CCh administration are shown compared to aCSF+CCh injected animals as
control group (black histograms). The long term enhancement of VEP amplitude is abolished in an identical manner by scopolamine, CPP and
mecamylamine, suggesting that mAChR and nAChR could act upstream of NMDAR intracellular pathways. Drug infusion time points are indicated by
black arrows.
doi:10.1371/journal.pone.0005995.g003
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there was no significant difference between the effect of CPP and the
one of i.c. scopolamine in terms of VEP amplitude. This might
indicate an all-or-none effect on VEP enhancement, suggesting
common intracellular pathways leading to LTP.
We propose that activation of mAChRs interact with intracel-
lular NMDAR pathways to induce cholinergic-induced long-term
effects on VEPs. It has been shown that M1 and M3 interact with
NMDAR pathways in the hippocampus by elevating intracellular
Ca
2+ levels and thereby enhancing the AMPA receptor currents
[46]. Post-synaptic mAChRs on pyramidal or spiny stellate cells
are able to induce PKC or AKT [34,35], which could be a
mechanism of such intracellular interaction. Moreover, in vitro
induction of LTP in V1 slices is impaired in M2/M4 mAChRs
double knock-out mice [24], suggesting that inhibition of M2/M4
mAChRs impaired LTP. Alternatively, the long-term enhance-
ment of VEP could result from an increase in VEP amplitude most
likely due to the number and nature of cells involved or a change
in the balance between LTP/LTD mechanisms induced. In this
case, the inhibition of the different subtypes of mAChRs located
on different cell types (GABA interneurons, pyramidal or spiny
stellate cells) could result in a decreased number of excitatory cells
activated by the paired visual stimulation and CCh infusion.
Involvement of nicotinic receptors
Mecamylamine, a non-selective nAChRs antagonist, and MLA
a selective a7 nAChR antagonist, were used to investigate the
potential involvement of nAChRs in the long-term enhancement
of VEPs. The a7 subtype of nAChRs is considered a key
participant in cortical plasticity [14], but its potential role in the
visual cortex has not been elucidated. Mecamylamine, but not
MLA, showed an impairment of long-term increases of VEP.
Results obtained with mecamylamine treatment were expected
since it has been shown that its administration abolished LTP
induced by tetanic stimulation of the dorsal geniculate nucleus in
V1 [21,22] and in V1 slice preparation [4]. These results have also
been observed in sound-evoked cortical response in the auditory
cortex [47]. Mecamylamine inhibits both a4b2 and a7 nAChRs
that are located on thalamocortical terminals and cortical
GABAergic neurons [14,15,48]. Activation of nAChRs located
on the thalamocortical afferents increase thalamic input [7].
Inhibition of these receptors should result in the reduction of
incoming signals from the thalamus which is in agreement with the
abolishment of VEP amplitude enhancement under mecamyl-
amine conditions in the current study. Inhibition of nAChRs
located on the GABAergic cells may not be sufficient to explain
these results since inhibition of these receptors should also result in
reducing the inhibitory drive within the intracortical network,
thereby lowering the threshold for eliciting a cortical response
[6,7,17]. In addition, it has been shown that mecamylamine could
transiently inhibit the NMDAR in vitro at the concentration used in
the present study [49]. It is possible that the blockade of CCh-
induced long-term effect on VEPs by mecamylamine in our study
could result from an inhibition of the NMDAR located on the
glutamatergic cells.
a7 nAChRs have been proposed to participate in cortical
plasticity by activating silent AMPA receptors on glutamatergic
neurons in the somatosensory cortex [17]. The blockade of a7
nAChRs in the present study did not consistently abolished the
long-term enhancement of VEP induced by concomitant thala-
mocortical and cholinergic activation. The amplitude of the VEP
response under MLA condition fluctuated, showing strong
increases or decreases depending on the time point. This effect
could be explained by an inactivation of GABAergic interneurons
rather than glutamatergic cells during the a7 nAChRs blockade.
Activation of a7 nAChRs of layer 1 interneurons has been shown
to mediate disinhibition of cortical networks [15], which can result
in increased VEP response. Consequently, inactivation of these
receptors could generate decreases in VEP amplitude, whereas,
increases in VEP amplitude could be induced by inhibition of
GABAergic cells from layer 4. Such blockade of a7 nAChRs has
been shown to induce LTP in the hippocampus [50,51] due to
their location on inhibitory interneurons [33].
Functional implication of the cholinergic modulation of
visual cortex
The permissive role by ACh shown here suggests that ACh is a
key factor in experience-dependent plasticity allowing cholinergic
enhanced stimuli to take over stimuli not associated with
cholinergic reinforcement and modifying both cortical processing
and representation of these stimuli. Our results bridge studies
showing the role of the cholinergic system in selective attention
(cholinergic reinforcement of visual stimuli) in V1 [1] and visual
learning (long-term modification of synaptic responses and
connections in V1) [2,12,52]. Our results imply that the
cholinergic reinforcement of visual stimuli 1) would be provided
by the adequately-timed cortical release of ACh from the basal
forebrain terminals [27,42] and 2) would be sufficient for visual
learning [42]. These implications are further supported by
previous work that ACh is released in cortex during numerous
learning paradigms [12,42], or visual stimulation [27,53]. This
release might be induced by sensory feed-forward influxes [27] or
by top-down control, in which ACh mediates top-down attention
mechanisms [1,52] elicited by higher cognitive areas through basal
forebrain activation [12,54]. This interplay between stimulus
driven and top-down input to modulate neuronal activity has been
addressed by computational neurosciences [55]. In the computa-
tional model, the authors suggest that a reinforcement signal
combined with an attention feedback signal, called attention-gated
reinforcement learning, could model the cortical integration and
mapping of sensory stimuli. The long-term mechanisms involving
NMDAR and probably LTP pathways shown in the present study,
suggest a modification of synaptic functioning by the cholinergic
system, which would give a neurobiological basis to this attention-
gated reinforcement learning. It would also suggest that attention
and visual stimuli elicit ACh release in V1, which modifies
synaptic functioning by eliciting LTP-like mechanisms at an early
level of cortical processing.
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